The growing interest in AI/Machine learning across industries has naturally extended to the pharmaceutical industry and life science sectors. As companies increasingly start to use AI tools, understanding both the expectations of regulatory authorities, when and how these tools can be used in GxP settings and also learn smart usage where AI can create value for Life Science is becoming essential.
Join us for an insightful session on the intersection between AI, GxP and Quality Management with PharmaRelations’ experts: Kent Wiberg, Nordic Head of QA, Hossein Asgari, Head of QA Denmark, and Niels Buch Leander, Chief Digital Officer.
Webinar Details
📅 Date: Wednesday, January 19, 2027
🕓 Time: 15:00 – 15:45 CET (45 minutes)
📍 Location: Online
Agenda:
🔹When and how can we in LifeScience use AI/Machine learning in the process
of developing and manufacturing drugs?
🔹Content in regulations and guidelines, like EU GMP Annex 22
🔹When will the use of AI be considered as GxP activity?
🔹If the AI use is considered as GxP activity, what is the demands?
🔹How to get authorities approval for using AI tools in LifeScience?
🔹Smart examples when the use of AI actually can create value for LifeScience

You will receive a booking confirmation shortly.
Vi kontaktar er så snart vi kan.
Niels Buch Leander, Ph.D., is an experienced digital leader and life sciences specialist with more than 15 years of consulting and executive experience across the biotech and pharmaceutical ecosystem. He is dedicated to accelerating digital transformation with focus on AI, data and processes. He is an experienced speaker and has delivered numerous trainings on AI and data in life sciences.
Kent have worked as employed in both large and small Pharma companies (AstraZeneca, Fresenius-Kabi, Vironova) and also Agencies (Läkemedelsverket, KemikalieInspektionen) for 26 years, where of 20 years in different management positions. His educational background is PhD in Analytical Chemistry, MSc in Chemistry and he have also LeanSigma BlackBelt certification. In 2022 he started his own company and work since then as sub-contractor and interim manager. His first assignment as consultant was in Sobi during 2022-2026 where he worked as Interim Head of Quality and Interim Head of Analytical Science.
Hossein is a biomedical engineer and quality leader with more than 17 years of experience in pharma and medical devices. His background covers manufacturing quality, supplier quality, QA, QC, audits and quality systems. Before joining PharmaRelations, he held leadership and quality roles at Gerresheimer, Xellia Pharmaceuticals, LEO Pharma, Novo Nordisk and Coloplast. Hossein have led teams across sites and countries and worked closely with internal and external stakeholders. As Head of Quality Assurance, Denmark, he work closely with customers and consultants and help develop our QA work in Denmark. I prefer open conversations and clear roles. Good quality needs to make sense in daily work.
PharmaRelations ApS
Hummeltoftevej 49
2830 Virum
DENMARK